These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 23482646

  • 1. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.
    Henriet SS, Jans J, Simonetti E, Kwon-Chung KJ, Rijs AJ, Hermans PW, Holland SM, de Jonge MI, Warris A.
    J Infect Dis; 2013 Jun 15; 207(12):1932-9. PubMed ID: 23482646
    [Abstract] [Full Text] [Related]

  • 2. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
    Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J.
    J Allergy Clin Immunol; 2011 May 15; 127(5):1243-52.e7. PubMed ID: 21376380
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
    Chang YC, Segal BH, Holland SM, Miller GF, Kwon-Chung KJ.
    J Clin Invest; 1998 May 01; 101(9):1843-50. PubMed ID: 9576747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction.
    Henriet SS, Verweij PE, Warris A.
    J Infect Dis; 2012 Oct 01; 206(7):1128-37. PubMed ID: 22829648
    [Abstract] [Full Text] [Related]

  • 7. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.
    Dotis J, Roilides E.
    Int J Infect Dis; 2004 Mar 01; 8(2):103-10. PubMed ID: 14732328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S, Davis MJ, Sugui JA, Pinkhasov T, Moyer S, Salazar AM, Chang YC, Kwon-Chung KJ.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588403
    [Abstract] [Full Text] [Related]

  • 10. Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.
    Henriet SS, Hermans PW, Verweij PE, Simonetti E, Holland SM, Sugui JA, Kwon-Chung KJ, Warris A.
    Infect Immun; 2011 Feb 27; 79(2):767-73. PubMed ID: 21078850
    [Abstract] [Full Text] [Related]

  • 11. Aspergillus nidulans infection in chronic granulomatous disease.
    Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM.
    Medicine (Baltimore); 1998 Sep 27; 77(5):345-54. PubMed ID: 9772923
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and treatment of aspergillosis in the patients with chronic granulomatous disease].
    Kurenko-Deptuch M, Wolska-Kuśnierz B, Heropolitańska-Pliszka E, Klaudel-Dreszler M, Pac M, Pietrucha B, Garczewska B, Bernatowska E.
    Przegl Epidemiol; 2006 Sep 27; 60(1):43-7. PubMed ID: 16758737
    [Abstract] [Full Text] [Related]

  • 13. Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease.
    Petersen JE, Hiran TS, Goebel WS, Johnson C, Murphy RC, Azmi FH, Hood AF, Travers JB, Dinauer MC.
    J Invest Dermatol; 2002 Mar 27; 118(3):424-9. PubMed ID: 11874480
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease.
    Seyedmousavi S, Chang YC, Law D, Birch M, Rex JH, Kwon-Chung KJ.
    Antimicrob Agents Chemother; 2019 Jun 27; 63(6):. PubMed ID: 30885903
    [Abstract] [Full Text] [Related]

  • 15. Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.
    Sfaihi L, Maaloul I, Fourati H, Stasia MJ, Mnif Z, Hachicha M.
    Fetal Pediatr Pathol; 2013 Jul 27; 32(4):241-5. PubMed ID: 23002911
    [Abstract] [Full Text] [Related]

  • 16. Detailed characterisation of invasive aspergillosis in a murine model of X-linked chronic granulomatous disease shows new insights in infections caused by Aspergillus fumigatus versus Aspergillus nidulans.
    King J, Dambuza IM, Reid DM, Yuecel R, Brown GD, Warris A.
    Front Cell Infect Microbiol; 2023 Jul 27; 13():1241770. PubMed ID: 37724291
    [Abstract] [Full Text] [Related]

  • 17. Multidrug resistance in Aspergillus fumigatus.
    Warris A, Weemaes CM, Verweij PE.
    N Engl J Med; 2002 Dec 26; 347(26):2173-4. PubMed ID: 12501236
    [No Abstract] [Full Text] [Related]

  • 18. Low interleukin-17A production in response to fungal pathogens in patients with chronic granulomatous disease.
    Smeekens SP, Henriet SS, Gresnigt MS, Joosten LA, Hermans PW, Netea MG, Warris A, van de Veerdonk FL.
    J Interferon Cytokine Res; 2012 Apr 26; 32(4):159-68. PubMed ID: 22191467
    [Abstract] [Full Text] [Related]

  • 19. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.
    De Luca A, Iannitti RG, Bozza S, Beau R, Casagrande A, D'Angelo C, Moretti S, Cunha C, Giovannini G, Massi-Benedetti C, Carvalho A, Boon L, Latgé JP, Romani L.
    J Clin Invest; 2012 May 26; 122(5):1816-31. PubMed ID: 22523066
    [Abstract] [Full Text] [Related]

  • 20. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.
    D'Angelo C, De Luca A, Zelante T, Bonifazi P, Moretti S, Giovannini G, Iannitti RG, Zagarella S, Bozza S, Campo S, Salvatori G, Romani L.
    J Immunol; 2009 Oct 01; 183(7):4609-18. PubMed ID: 19734205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.